Social Toolkit
Secure Our Meds is an advocacy campaign with policy solutions to strengthen the generic and biosimilar supply chain and ensure our medicines get on the market and stay there. Learn more through our resources and help us spread the word through social media. #SecureOurMeds
Follow Us
Follow AAM
Website: accessiblemeds.org
Twitter: @accessiblemeds
Facebook: @accessiblemeds
Instagram: @accessiblemeds
LinkedIn: /company/accessiblemeds
Follow Biosimilars Council
Website: biosimilarscouncil.org
Twitter: @BiosimsCouncil
Facebook: @BiosimsCouncil
LinkedIn: /company/biosimscouncil
Take Action
- Follow and share AAM’s Twitter posts: #SecureOurMeds
- View and share AAM’s YouTube Video: The Generics and Biosimilars Industry Has a Plan to Secure Our Medicines
- Tell us about your experience filling generic and biosimilar prescriptions
Social Sharing Examples
We encourage you to include the hashtag #SecureOurMeds in your tweets and tag @accessiblemeds and @biosimscouncil in all posts so we can share your message!
Right-click on any image to download. Or visit our Dropbox for more images to choose from.
Discover solutions to #SecureOurMeds for patients by enhancing supply chains and strengthening grx and biosim markets. https://www.secureourmeds.org/ #genericdrugs #biosimilars #healthcare #healthpolicy
Generic and biosimilar markets face significant challenges that threaten sustainable patient access to affordable treatments as well as billions in annual savings for the U.S. health care system. Let’s work together to secure patient access to these essential medicines. https://secureourmeds.org/ #SecureOurMeds #generics #biosimilars #patientaccess #healthcare #healthpolicy
The generics and biosimilars industry is committed to making the supply chain stronger and more secure. Our AAM Blueprint outlines ways for Congress to incentivize further U.S. manufacturing and also strengthen ties with our allies to enhance resilience. https://secureourmeds.org/blueprint/ #SecureOurMeds #AAMBlueprint #healthcare #healthpolicy
Among total health plan costs, generics accounted for only 2% of premiums — compared to 9% driven by brand and specialty prescription drugs. Learn more at https://secureourmeds.org/securing-sustainable-markets/ #SecureOurMeds #patientaccess #genericdrugs
The U.S. #supplychain for generic prescription drugs has held strong during the pandemic. For patients, that means continued savings when it counts most. Read report: https://secureourmeds.org/securing-sustainable-markets/ #SecureOurMeds #patientaccess #genericdrugs
Once generic and biosimilar medicines obtain FDA approval, they easily launch into the U.S. market, right? Wrong! Learn about the obstacles that come between prescription drugs and the patients who need them: https://secureourmeds.org/securing-sustainable-markets/ #SecureOurMeds #patientaccess #genericdrugs
America’s seniors pay more for low-cost generics — sometimes even paying the full cost of the drug with no help from their own health plan to which they pay premiums. Find out why at https://secureourmeds.org/securing-sustainablemarkets/ #SecureOurMeds #patientaccess #genericdrugs
Have Questions?
If you need assistance, please contact AAM Senior Marketing Director Erica Klinger at Erica.Klinger@accessiblemeds.org.
Download our complete toolkit here.